Target intelligence / Profile preview

Neurokinin Type 1 Receptor (NK1R)

Target
NK1R
Molecular classification
G protein-coupled receptor, GPCR, Tachykinin receptor subfamily
01

Overview

The Neurokinin Type 1 Receptor (NK1R), also known as TACR1 or Substance P Receptor, is a G protein-coupled receptor belonging to the tachykinin receptor subfamily. It is activated primarily by the neuropeptide substance P (SP) and plays a crucial role in various physiological processes, including pain transmission, stress response, emesis, vasodilation, and immune modulation. NK1R is widely distributed throughout the central and peripheral nervous systems and peripheral tissues. Antagonists targeting NK1R, such as aprepitant, are used as antiemetics to prevent chemotherapy-induced nausea and vomiting. Research is ongoing to explore their potential use in treating mood disorders and cancer.

Other names
Tachykinin receptor 1TACR1Substance P receptorSPR
02

Mechanism of action

NK1R antagonists bind to and block the neurokinin 1 receptor, preventing substance P from binding and activating the receptor. This inhibits downstream signaling pathways, including activation of phospholipase Cβ and increased intracellular calcium concentration.

03

Biological functions

Pain transmission/sensory neuronal signalingModulation of stress/anxiety responsesEmesis/vomiting reflexVasodilationEndocrine/paracrine secretionCell proliferation modulationImmune system regulationInflammation mediationSignal transduction
04

Disease associations

PainAnxietyNausea/VomitingInflammationCancer
05

Interacting drugs

Aprepitant

1 more in the full profile.

Beyond the preview

Go deeper on Neurokinin Type 1 Receptor (NK1R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurokinin Type 1 Receptor (NK1R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call